Medication info
Teneglo M Sustained-Release Tablet 10/750 mg

Teneglo M Sustained-Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Yellow oval sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202260 · Approved 2022.05.25 · Insurance code 640904300

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablets once daily. Patients taking 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the patient's existing doses of teneligliptin and metformin. When converting from immediate-release to extended-release metformin, glycemic control should be closely monitored and dose adjustments made as appropriate. When used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other blood glucose-lowering agents. Because changes may affect glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It contains both teneligliptin and metformin, making it effective as a therapeutic agent that complements dietary and exercise therapy. It helps lower blood sugar levels to prevent complications and supports the health management of patients. Therefore, consistent use can aid in blood sugar management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablets once daily. Patients taking 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the patient's existing doses of teneligliptin and metformin. When converting from immediate-release to extended-release metformin, glycemic control should be closely monitored and dose adjustments made as appropriate. When used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other blood glucose-lowering agents. Because changes may affect glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication helps control blood sugar. However, it should not be used by patients with poor kidney function or those with heart disease. Additionally, it should be temporarily discontinued in cases of acute infection, severe trauma, or before and after surgery. This medication can rarely cause a serious side effect known as lactic acidosis, so if symptoms such as difficulty breathing, muscle pain, weakness, or abdominal pain occur, consult a doctor immediately. Furthermore, hypoglycemic symptoms may occur, so caution is advised if meals are skipped or excessive exercise is undertaken. Patients with impaired liver function or those who consume alcohol excessively should also avoid this medication. It is advised that women who are pregnant or may become pregnant, as well as breastfeeding women, do not use this medication. Elderly patients may experience reduced kidney function, so regular checks and dosage adjustments are necessary. While taking this medication, if used with other diabetes medications, the risk of hypoglycemia may increase, so it is important to be well-informed about hypoglycemic symptoms and responses. Additionally, this medication should be discontinued before tests that use certain contrast agents and resumed only after kidney function is confirmed to be normal following the tests. It is important to regularly check kidney function and vitamin B12 levels through blood tests while taking this medication. Side effects such as constipation, abdominal pain, dizziness, and rash may occur; consult a doctor if symptoms are severe. Lastly, the safety and efficacy of this medication have not been confirmed in children, so it is not used in pediatric patients.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • drug-induced dermatitis herpetiformis
  • acute pancreatitis
  • dizziness
Show 114 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • elevated serum potassium levels
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • asthenia
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic encephalopathy
  • lumbar spinal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral stones
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataracts
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • primary hyperparathyroidism
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • hearing loss
  • endolymphatic hydrops
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air exposure. It is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the efficacy of the medication for longer.

Appearance and packaging

Appearance

Yellow oval sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.